New Year’s Sale — Build a balanced news diet with 40% off Vantage

Published 2 days ago • loading... • Updated 2 days ago

Muna Therapeutics Awarded $1 Million Alzheimer's Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer's

Summary by PR Newswire

/PRNewswire/ -- Muna Therapeutics, a clinical-stage biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases, today...

12 Articles

12 Articles

miltonindependent.com

+11 Reposted by 11 other sources

Muna Therapeutics Awarded $1 Million Alzheimer's Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer's

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's

2 days ago·Milton, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources12

Leaning Left1Leaning Right0Center2Last Updated13 hours agoBias Distribution

67% Center

Bias Distribution

67% of the sources are Center

67% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States 2 days ago on Thursday, January 8, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics